Health workers Luke (Kenya), Juliana (Colombia), and Shishu (India) share the same hope for their patients with leishmaniasis: simple, oral treatments.
Leishmaniasis is one of the world's most neglected diseases, affecting over a million people every year. Many of the drugs that are used are 70 years old and are toxic, expensive, or difficult to take.
But Luke, Juliana, and Shishu see a glimmer of hope: research is being conducted in their countries which can lead to a new generation of treatments. For the first time ever, it seems leishmaniasis research is moving from neglect to a sense of hope.
Find out about our work on visceral leishmaniasis and cutaneous leishmaniasis